MedpaceMEDP
Market Cap: $10.4B
About: Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Employees: 5,800
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
54% more first-time investments, than exits
New positions opened: 74 | Existing positions closed: 48
8% more funds holding in top 10
Funds holding in top 10: 12 [Q1] → 13 (+1) [Q2]
4% more funds holding
Funds holding: 587 [Q1] → 613 (+26) [Q2]
2% more repeat investments, than reductions
Existing positions increased: 235 | Existing positions reduced: 231
1% more capital invested
Capital invested by funds: $10.3B [Q1] → $10.4B (+$97.8M) [Q2]
0.33% less ownership
Funds ownership: 82.67% [Q1] → 82.34% (-0.33%) [Q2]
51% less call options, than puts
Call options by funds: $17.3M | Put options by funds: $35M
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
6 analyst ratings
Truist Securities Jailendra Singh 52% 1-year accuracy 17 / 33 met price target | 24%upside $415 | Hold Initiated | 1 Aug 2024 |
Baird Eric Coldwell 53% 1-year accuracy 16 / 30 met price target | 28%upside $430 | Outperform Maintained | 24 Jul 2024 |
Deutsche Bank Justin Bowers 83% 1-year accuracy 5 / 6 met price target | 0%upside $336 | Hold Maintained | 24 Jul 2024 |
TD Cowen Charles Rhyee 29% 1-year accuracy 2 / 7 met price target | 29%upside $434 | Buy Maintained | 24 Jul 2024 |
Guggenheim Sandy Draper 20% 1-year accuracy 1 / 5 met price target | 29%upside $432 | Buy Maintained | 24 Jul 2024 |
Financial journalist opinion
Based on 56 articles about MEDP published over the past 30 days